vTv Therapeutics (VTVT) Misses Q2 EPS by 15c

vTv Therapeutics (NASDAQ: VTVT) reported Q2 EPS of ($1.05), $0.15 worse than the analyst estimate of ($0.90).

For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.

You May Also Be Interested In

• Costco (COST) Tops Q4 EPS by 20c
• YYForce posts 26.8% revenue gain but widens net loss in H1 2026
• Northrop Grumman wins three U.S. defense contracts worth $308M